Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-12-10
pubmed:abstractText
ST1481 is the lead compound of a novel series of 7-modified camptothecins, the 7-oxyimino methyl derivatives, characterized by potent topoisomerase I inhibition and cytotoxic activity. Based on its therapeutic efficacy in a human non-small cell lung carcinoma model and its favorable pharmacological profile, the novel analogue was selected for further preclinical development.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3904-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12473606-Administration, Oral, pubmed-meshheading:12473606-Animals, pubmed-meshheading:12473606-Antineoplastic Agents, Phytogenic, pubmed-meshheading:12473606-Camptothecin, pubmed-meshheading:12473606-Cell Cycle, pubmed-meshheading:12473606-Cell Division, pubmed-meshheading:12473606-Drug Resistance, Neoplasm, pubmed-meshheading:12473606-Drug Screening Assays, Antitumor, pubmed-meshheading:12473606-Enzyme Inhibitors, pubmed-meshheading:12473606-Female, pubmed-meshheading:12473606-Humans, pubmed-meshheading:12473606-Mice, pubmed-meshheading:12473606-Mice, Nude, pubmed-meshheading:12473606-Neoplasms, Experimental, pubmed-meshheading:12473606-Topoisomerase I Inhibitors, pubmed-meshheading:12473606-Topotecan, pubmed-meshheading:12473606-Tumor Cells, Cultured, pubmed-meshheading:12473606-Xenograft Model Antitumor Assays
pubmed:year
2002
pubmed:articleTitle
Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
pubmed:affiliation
Istituto Nazionale Tumori, 20133 Milan, Italy. graziella.pratesi@istitutotumori.mi.it
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't